AGED Diagnostics Liver Disease Assessment
Public ClinicalTrials.gov record NCT06348563. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
AGED Diagnostics Epigenetic Modifications of Liver Disease Assessment
Study identification
- NCT ID
- NCT06348563
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Early Phase 1
- Lead sponsor
- Active Genomes Expressed Diagnostics, Corp
- Industry
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- AGED Multiple Target Assay in Healthy Controls Diagnostic Test
- AGED Multiple Target Assay in NAFLD Participants Diagnostic Test
- AGED Multiple Target Assay in Fibrosis Participants Diagnostic Test
Diagnostic Test
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 14, 2024
- Primary completion
- May 14, 2025
- Completion
- Sep 14, 2025
- Last update posted
- Apr 3, 2024
2024 – 2025
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AGED Diagnostics | Bethesda | Maryland | 20002 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06348563, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 3, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06348563 live on ClinicalTrials.gov.